Stocks and Investing
Stocks and Investing
Fri, October 1, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, September 30, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Bradley Canino Initiated (ZNTL) at Strong Buy and Held Target at $84 on, Sep 30th, 2021
Bradley Canino of Stifel, Initiated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $84 on, Sep 30th, 2021.
Bradley has made no other calls on ZNTL in the last 4 months.
There is 1 other peer that has a rating on ZNTL. Out of the 1 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.
This is the rating of the analyst that currently disagrees with Bradley
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Contributing Sources